Autonomize AI Appoints Dr. Anthony Nguyen as Chief Medical Officer and Head of Strategy

Former Chief Clinical Officer at Elevance Health to lead Autonomize AI’s efforts in Payers and Providers

AUSTIN, Texas--()--Autonomize AI, a leading AI company in healthcare and life sciences, announces the appointment of Dr. Anthony Nguyen as its new Head of Strategy and Chief Medical Officer, effective December 1, 2023. This strategic addition to the team is set to accelerate the company’s endeavors in delivering AI-driven solutions for the healthcare sector, aiming to enhance patient outcomes and improve operational efficiencies.

Background and Experience

Dr. Nguyen brings a wealth of experience to Autonomize AI, having previously held significant roles in health plans like Elevance Health and UnitedHealthcare. His expertise in clinical medicine, combined with a strong track record in strategic planning and digital health innovation, aligns perfectly with Autonomize AI’s vision. Dr. Nguyen's appointment underscores the company's commitment to integrating deep medical knowledge with cutting-edge AI technologies.

"I am thrilled to be part of Autonomize AI, a company that is exceptionally well-positioned to transform healthcare,” said Dr. Nguyen. He continued, “What excites me most is Autonomize AI's leadership in AI, coupled with their extensive capabilities across various healthcare sectors, including providers, payors, and life sciences. Joining a team that is actively making a tangible difference in the industry is a unique opportunity."

In his role as Chief Medical Officer, Dr. Nguyen will oversee the strategic direction of Autonomize AI's product development and implementation in healthcare settings.

Ganesh Padmanabhan, Autonomize AI founder and CEO, stated, "Welcoming Dr. Anthony Nguyen as our Chief Medical Officer & Head of Strategy marks a pivotal moment for Autonomize AI. His blend of clinical insight and strategic thinking aligns seamlessly with our mission to empower healthcare workers through advanced AI tools. His joining reinforces our belief that the strength and success of our company are directly linked to the quality of our team. We're confident that his contribution will be instrumental in advancing our vision of transforming healthcare with AI."

Impact and Future Directions

As the healthcare industry continues to evolve, the role of AI becomes increasingly significant. Autonomize AI, with Dr. Nguyen at the helm of its strategic direction, is poised to be at the forefront of this transformation, contributing to a future where technology and healthcare intersect for the betterment of patient outcomes and healthcare delivery efficiency.

About Autonomize AI

Autonomize’s AI products organize, contextualize and summarize unstructured data so healthcare knowledge workers can make data-driven decisions, to improve patient outcomes. With a deep commitment to privacy, trust and security, the Enterprise Generative AI platform from Autonomize is a domain-adapted offering for regulated industries. Autonomize AI is a founding member of CancerX, the US President Biden’s Cancer Moonshot initiative. Their customers include Top 20 pharma, F100 Payors and life sciences companies. Learn more at